Cargando…

Serum calcitonin nadirs to undetectable levels within 1 month of curative surgery in medullary thyroid cancer

OBJECTIVE: Because serum calcitonin (CT) is a reliable marker of the presence, volume, and extent of disease in medullary thyroid cancer (MTC), both the ATA and NCCN guidelines use the 2-3 month post-operative CT value as the primary response to therapy variable that determines the type and intensit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Andrade, Fernanda, Rondeau, Geneviève, Boucai, Laura, Zeuren, Rebecca, Shaha, Ashok R., Ganly, Ian, Vaisman, Fernanda, Corbo, Rossana, Tuttle, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedade Brasileira de Endocrinologia e Metabologia 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6639090/ https://www.ncbi.nlm.nih.gov/pubmed/30916162 http://dx.doi.org/10.20945/2359-3997000000112

Ejemplares similares

Thyroid Carcinoma in Children and Adolescents—Systematic Review of the Literature
por: Vaisman, Fernanda, et al.
Publicado: (2011)

Low but not undetectable early postoperative nadir serum cortisol predicts sustained remission in Cushing’s disease
por: Stroud, Anna, et al.
Publicado: (2022)

Serum calcitonin negative Medullary thyroid carcinoma
por: Sand, Michael, et al.
Publicado: (2006)

Calcitonin receptor expression in medullary thyroid carcinoma
por: Cappagli, Virginia, et al.
Publicado: (2017)

No calcitonin change in a person taking dulaglutide diagnosed with pre‐existing medullary thyroid cancer
por: Sherman, S. I., et al.
Publicado: (2018)

Oncologic outcomes of calcitonin-negative medullary thyroid carcinoma
por: Yue, Wenliang, et al.
Publicado: (2022)

Role of vandetanib in the management of medullary thyroid cancer
por: Brassard, Maryse, et al.
Publicado: (2012)

Thyroid Lobectomy Is Associated with Excellent Clinical Outcomes in Properly Selected Differentiated Thyroid Cancer Patients with Primary Tumors Greater Than 1 cm
por: Vaisman, Fernanda, et al.
Publicado: (2013)

Serum calcitonin estimation in medullary thyroid cancer: basal or stimulated levels?
por: Daumerie, Chantal, et al.
Publicado: (2013)

The Difficulty of Post-Operative Surveillance of Calcitonin Negative Medullary Thyroid Cancer
por: Skutnik, Emily, et al.
Publicado: (2021)

Pregnancy has no significant impact on the prognosis of differentiated thyroid cancer
por: Nobre, Gabriela Maia, et al.
Publicado: (2021)

Nadir PSA level and time to nadir PSA are prognostic factors in patients with metastatic prostate cancer
por: Tomioka, Atsushi, et al.
Publicado: (2014)

Is radioactive iodine- ( 131 ) treatment related to the occurrence of non-synchronous second primary malignancy in patients with differentiated thyroid cancer?
por: de Souza, Marcelo Cruzick, et al.
Publicado: (2015)

Preoperative Serum Calcitonin Level and Ultrasonographic Characteristics Predict the Risk of Metastatic Medullary Thyroid Carcinoma: Functional Analysis of Calcitonin-Related Genes
por: Fan, Yi, et al.
Publicado: (2022)

Puberty and sex in pediatric thyroid cancer: could expression of estrogen and progesterone receptors affect prognosis?
por: da Silva Breder, Julia Ramalho Amalio, et al.
Publicado: (2022)

Medullary thyroid carcinoma and duodenal calcitonin-secreting neuroendocrine tumour: more than coincidence?
por: Huguet, I, et al.
Publicado: (2013)

False positive results using calcitonin as a screening method for medullary thyroid carcinoma
por: Batista, Rafael Loch, et al.
Publicado: (2013)

Calcitonin negative Medullary Thyroid Carcinoma: a challenging diagnosis or a medical dilemma?
por: Gambardella, Claudio, et al.
Publicado: (2019)

Prognostic Value of Preoperative Serum Calcitonin Levels for Predicting the Recurrence of Medullary Thyroid Carcinoma
por: Park, Hyunju, et al.
Publicado: (2021)

Basal and stimulated calcitonin for the diagnosis of medullary thyroid cancer: updated thresholds and safety assessment
por: Fugazzola, L., et al.
Publicado: (2020)

ODP466 Case of Sporadic Medullary Thyroid Cancer Detected by Serum Calcitonin Measurement
por: Juneau, Andrea Kate, et al.
Publicado: (2022)

Early postoperative calcitonin-to-preoperative calcitonin ratio as a predictive marker for structural recurrence in sporadic medullary thyroid cancer: A retrospective study
por: Jiao, Zan, et al.
Publicado: (2022)

Metastatic lymph node characteristics as predictors of recurrence/persistence in the neck and distant metastases in differentiated thyroid cancer
por: Barbosa, Mayara Peres, et al.
Publicado: (2017)

Preoperative Serum Calcitonin and Its Correlation with Extent of Lymph Node Metastasis in Medullary Thyroid Carcinoma
por: Park, Hyunju, et al.
Publicado: (2020)

Basal and pentagastrin-stimulated calcitonin cut-off values in diagnosis of preoperative medullary thyroid cancer
por: KARTAL BAYKAN1, Emine, et al.
Publicado: (2021)

Does pretreatment elevated calcitonin level cause the poor prognosis in patients with medullary thyroid cancer?
por: Zhang, Han, et al.
Publicado: (2022)

The leucocyte nadir, a predictor of chemotherapy efficacy?
por: Kvinnsland, S
Publicado: (1999)

Reaching the Nadir of Medication Overuse in Chronic Migraine
por: Onan, Dilara, et al.
Publicado: (2022)

GRADING OF MEDULLARY THYROID CARCINOMA ON THE BASIS OF TUMOR NECROSIS AND HIGH MITOTIC RATE IS AN INDEPENDENT PREDICTOR OF POOR OUTCOME
por: Alzumaili, Bayan, et al.
Publicado: (2020)

Lymph Node Metastases of Medullary Thyroid Cancer: Role of Calcitonin in the Washout Fluid of Fine-Needle Aspiration
por: Marques, Bernardo, et al.
Publicado: (2020)

Medullary thyroid carcinoma with double negative calcitonin and CEA: a case report and update of literature review
por: Gambardella, Claudio, et al.
Publicado: (2019)

Preoperative serum calcitonin may improve initial surgery for medullary thyroid cancer in patients with indeterminate cytology
por: Jassal, Karishma, et al.
Publicado: (2022)

Case Report: A Challenging Clinical Problem of Calcitonin-Negative Medullary Thyroid Cancer Diagnosis and Surveillance
por: Rafaey, Wania, et al.
Publicado: (2022)

SAT560 A Case of Medullary Thyroid Carcinoma with Increasing Carcinoembryonic Antigen and Stable Calcitonin Levels
por: Youssef, Kerolos N, et al.
Publicado: (2023)

Early calcitonin levels in medullary thyroid carcinoma: Prognostic role in patients without distant metastases at diagnosis
por: Sparano, Clotilde, et al.
Publicado: (2023)

Circulating calcitonin and carcinoembryonic antigen m-RNA detected by RT-PCR as tumour markers in medullary thyroid carcinoma
por: Bojunga, J, et al.
Publicado: (2001)

Identification of occult metastases of medullary thyroid carcinoma by pentagastrin-stimulated intravenous calcitonin sampling followed by targeted surgery
por: Schott, Matthias, et al.
Publicado: (2007)

Plasma Calcitonin Levels and miRNA323 Expression in Medullary Thyroid Carcinoma Patients with or without RET Mutation
por: Ehyaei, Samira, et al.
Publicado: (2017)

Calcitonin Non-Secreting Mixed Medullary-Papillary Thyroid Carcinoma: Report of a Rare Entity and Therapeutic Implications
por: Oleinikov, Kira, et al.
Publicado: (2021)

Serum Calcitonin-Negative Medullary Thyroid Carcinoma: A Case Series of 19 Patients in a Single Center
por: Kim, Sun Jung, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_aa7lg97rf6ii9ipqvk21i116g7